share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer Michael Robert A.

SEC announcement ·  Mar 2 06:55
Summary by Futu AI
Michael Robert A., President and Chief Operating Officer of AbbVie Inc., completed a series of stock transactions between February 28, 2024, and February 29, 2024. The transactions involved the sale of a total of 106,517 shares of common stock at prices ranging from $176.44 to $178.99, resulting in a total market value of $18,890,782.76. Additionally, Michael Robert A. acquired 21,560 shares through the exercise or conversion of derivative securities at prices between $54.86 and $61.36. Following these transactions, Michael Robert A. holds a total of 98,645 shares of AbbVie common stock.
Michael Robert A., President and Chief Operating Officer of AbbVie Inc., completed a series of stock transactions between February 28, 2024, and February 29, 2024. The transactions involved the sale of a total of 106,517 shares of common stock at prices ranging from $176.44 to $178.99, resulting in a total market value of $18,890,782.76. Additionally, Michael Robert A. acquired 21,560 shares through the exercise or conversion of derivative securities at prices between $54.86 and $61.36. Following these transactions, Michael Robert A. holds a total of 98,645 shares of AbbVie common stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.